+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2020

  • ID: 5230857
  • Report
  • December 2020
  • Region: Global
  • 96 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Alievio Inc
  • Corneat Vision Ltd
  • InnFocus Inc
  • Meir Medical Center
  • OcuTherix Inc
  • Queen's University
  • MORE
Summary

The publisher's Medical Devices sector report, “Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Glaucoma Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure. This category includes glaucoma drainage devices and canaloplasty micro catheters.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Glaucoma Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Glaucoma Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Alievio Inc
  • Corneat Vision Ltd
  • InnFocus Inc
  • Meir Medical Center
  • OcuTherix Inc
  • Queen's University
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Glaucoma Surgery Devices Overview

3 Products under Development
3.1 Glaucoma Surgery Devices - Pipeline Products by Stage of Development
3.2 Glaucoma Surgery Devices - Pipeline Products by Segment
3.3 Glaucoma Surgery Devices - Pipeline Products by Territory
3.4 Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
3.5 Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
3.6 Glaucoma Surgery Devices - Ongoing Clinical Trials

4 Glaucoma Surgery Devices - Pipeline Products under Development by Companies
4.1 Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
4.2 Glaucoma Surgery Devices - Pipeline Products by Stage of Development

5 Glaucoma Surgery Devices Companies and Product Overview
5.1 Alievio Inc Company Overview
5.1.1 Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Allergan Ltd Company Overview
5.2.1 Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Assenti, LLC Company Overview
5.3.1 Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Avisi Technologies LLC Company Overview
5.4.1 Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 Corneat Vision Ltd Company Overview
5.5.1 Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Eye Sonix Company Overview
5.6.1 Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview
5.7 Galaxy Ophthalmics Inc (Inactive) Company Overview
5.7.1 Galaxy Ophthalmics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.8 Geuder AG Company Overview
5.8.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
5.9 Glaukos Corp Company Overview
5.9.1 Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 InnFocus Inc Company Overview
5.10.1 InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 iScience Interventional Inc Company Overview
5.11.1 iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 iSTAR Medical SA Company Overview
5.12.1 iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.13 iVeena Delivery Systems Inc Company Overview
5.13.1 iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Johns Hopkins University Company Overview
5.14.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.15 Kytogenics Pharmaceuticals Inc Company Overview
5.15.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Medtronic Plc Company Overview
5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Meir Medical Center Company Overview
5.17.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.18 Merz Anteis SA Company Overview
5.18.1 Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview
5.19 MicroOptx, Inc. Company Overview
5.19.1 MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.20 Ocumatrx Company Overview
5.20.1 Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview
5.21 OcuTherix Inc Company Overview
5.21.1 OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 OPKO Health Inc Company Overview
5.22.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 OptoLight Vision Technology Company Overview
5.23.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview
5.24 Purdue University Company Overview
5.24.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
5.25 Quantel Medical SA Company Overview
5.25.1 Quantel Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.26 Queen's University Company Overview
5.26.1 Queen's University Pipeline Products & Ongoing Clinical Trials Overview
5.27 Sheba Medical Center Company Overview
5.27.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.28 Sight Sciences Inc Company Overview
5.28.1 Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 SOLX Inc Company Overview
5.29.1 SOLX Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Tel Aviv University Company Overview
5.30.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Colorado Company Overview
5.31.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.32 University of Michigan Company Overview
5.32.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.33 Westhouse Medical Services Plc (Inactive) Company Overview
5.33.1 Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

6 Glaucoma Surgery Devices- Recent Developments
6.1 Oct 30, 2020: PolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch + Lomb executive, to its Board of Directors
6.2 Sep 07, 2020: Pomerantz law firm announces the filing of a class action against Staar Surgical Company and certain officers - STAA
6.3 May 13, 2020: OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network enter into strategic laboratory collaboration to deliver operational and diagnostic services
6.4 Apr 13, 2020: STAAR Surgical provides covid-19 business update
6.5 Apr 07, 2020: Alcon provides update on covid-19
6.6 Mar 12, 2020: Ocular Therapeutix reports fourth quarter and year end 2019 financial results and business update
6.7 Mar 10, 2020: Sight Sciences announces publication of first-ever multicenter MIGS study in childhood glaucoma
6.8 Mar 03, 2020: Ocular Therapeutix announces preliminary fourth quarter 2019 net product revenue
6.9 Feb 26, 2020: STAAR Surgical reports fourth quarter and full year 2019 results
6.10 Feb 26, 2020: NanoString Technologies releases fourth quarter and full year 2019 operating results and provides 2020 financial outlook
6.11 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.12 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.13 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.14 Jan 15, 2020: ELT Sight announces scientific advisory board
6.15 Jan 13, 2020: STAAR Surgical reports preliminary fourth quarter net sales growth of 25%
6.16 Dec 18, 2019: STAAR CFO to retire in 2020
6.17 Dec 09, 2019: Sight Sciences appoints Erica Rogers to its Board of Directors
6.18 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Table 2: Glaucoma Surgery Devices - Pipeline Products by Segment
Table 3: Glaucoma Surgery Devices - Pipeline Products by Territory
Table 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Table 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Table 6: Glaucoma Surgery Devices - Ongoing Clinical Trials
Table 7: Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
Table 8: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Table 9: Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Camras Shunt - Product Status
Table 11: Camras Shunt - Product Description
Table 12: Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 13: XEN63 - Product Status
Table 14: XEN63 - Product Description
Table 15: Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Intraocular Pressure Monitoring System - Product Status
Table 17: Intraocular Pressure Monitoring System - Product Description
Table 18: Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 19: VisiPlate - Product Status
Table 20: VisiPlate - Product Description
Table 21: Corneat Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: CorNeat eShunt - Product Status
Table 23: CorNeat eShunt - Product Description
Table 24: Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Therapeutic Ultrasound Device - Glaucoma - Product Status
Table 26: Therapeutic Ultrasound Device - Glaucoma - Product Description
Table 27: Galaxy Ophthalmics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Titan Shunt - Product Status
Table 29: Titan Shunt - Product Description
Table 30: Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Microsystem Implant - Product Status
Table 32: Microsystem Implant - Product Description
Table 33: Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 34: iStent Infinite Trabecular Micro-Bypass System - Product Status
Table 35: iStent Infinite Trabecular Micro-Bypass System - Product Description
Table 36: iStent SA Trabecular Micro-Bypass System - Product Status
Table 37: iStent SA Trabecular Micro-Bypass System - Product Description
Table 38: iStent Supra Suprachoroidal Micro-Bypass Stent - Product Status
Table 39: iStent Supra Suprachoroidal Micro-Bypass Stent - Product Description
Table 40: Glaukos Corp - Ongoing Clinical Trials Overview
Table 41: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent
Table 42: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects with Cataract Treated with Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent
Table 43: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 in Conjunction with Cataract Surgery
Table 44: iStent SA Trabecular Micro-Bypass System - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication (Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject)
Table 45: iStent SA Trabecular Micro-Bypass System - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications (One a Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject) and a Postoperative Topical Prostaglandin
Table 46: iStent SA Trabecular Micro-Bypass System - Initial Phase of U.S. IDE Clinical Trial for Standalone Version of iStent inject
Table 47: iStent SA Trabecular Micro-Bypass System - Trabeculectomy with MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors
Table 48: iStent Infinite Trabecular Micro-Bypass System - A Prospective, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-bypass System, Model iS3, in Subjects with Refractory Glaucoma
Table 49: InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: PreserFlo MicroShunt - Product Status

List of Figures
Figure 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Figure 2: Glaucoma Surgery Devices - Pipeline Products by Segment
Figure 3: Glaucoma Surgery Devices - Pipeline Products by Territory
Figure 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Figure 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Glaucoma Surgery Devices - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Alievio Inc
  • Allergan Ltd
  • Assenti, LLC
  • Avisi Technologies LLC
  • Corneat Vision Ltd
  • Eye Sonix
  • Galaxy Ophthalmics Inc (Inactive)
  • Geuder AG
  • Glaukos Corp
  • InnFocus Inc
  • iScience Interventional Inc
  • iSTAR Medical SA
  • iVeena Delivery Systems Inc
  • Johns Hopkins University
  • Kytogenics Pharmaceuticals Inc
  • Medtronic Plc
  • Meir Medical Center
  • Merz Anteis SA
  • MicroOptx, Inc.
  • Ocumatrx
  • OcuTherix Inc
  • OPKO Health Inc
  • OptoLight Vision Technology
  • Purdue University
  • Quantel Medical SA
  • Queen's University
  • Sheba Medical Center
  • Sight Sciences Inc
  • SOLX Inc
  • Tel Aviv University
  • University of Colorado
  • University of Michigan
  • Westhouse Medical Services Plc (Inactive)
Note: Product cover images may vary from those shown
Adroll
adroll